Study of Safety and Efficacy Of PF-04971729 In Patients With Type 2 Diabetes And Hypertensio
Phase 2
Completed
- Conditions
- Health Condition 1: null- Diabetes Mellitus, Type 2Hypertension
- Registration Number
- CTRI/2010/091/001073
- Lead Sponsor
- Pfizer Limited
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 175
Inclusion Criteria
Ages Eligible for Study: 18 Years to 65 Years
Genders Eligible for Study: Both
Accepts Healthy Volunteers: No
1.Patients with type 2 diabetes and hypertension
2.Medically stable
3.On at least 1 (and up to 2) oral diabetes drugs
4.And up to 2 medicines for blood pressure control
Exclusion Criteria
1.Patients with type 1 diabetes
2.Heart attack
3.Stroke
4.Uncontrolled blood pressure
5.Significant kidney disease
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method